CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Allero Therapeutics is developing a novel immunotherapy for Celiac Disease, utilizing a sublingual mouth patch for delivery. This project aims to establish a new treatment option by combining antigen-specific therapy with tolerizing agents.
Celiac Disease is a debilitating autoimmune disorder that is caused by intolerance to gluten.
Although it is the most common genetically-based food intolerance in the world, there are currently no therapeutics available to treat patients.
In this project, Allero Therapeutics will collaborate with two leading research institutes (Leiden University Medical Center from the Netherlands and the Veterinary Research Institute from the Czech Republic) to develop a first-in-class therapeutic against Celi…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
